OverviewChartNewsTraderScreen

HSBC DIS.CERT. 12/24 AMD/  DE000HG98RP3  /

gettex Zettex2
2024-09-02  9:35:50 AM Chg.-0.050 Bid10:15:38 AM Ask10:15:38 AM Underlying Strike price Expiration date Option type
48.840EUR -0.10% 48.760
Bid Size: 5,000		 48.860
Ask Size: 5,000		 ADVANCED MIC.DEV. D... - - 2024-12-30 Call
TeleTrader 08-28 Dow down by 350 pts with tech sector in focus
GlobeNewswire 08-20 AMD to Present at the Deutsche Bank Technology Conference
GlobeNewswire 08-20 FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facil...
GlobeNewswire 08-20 Gamescom 2024 - HP Elevates the Gaming World through Customizable Solutions for a Personalized Playe...
TeleTrader 08-19 US closes higher on tech sell-off
TeleTrader 08-19 AMD to buy server maker ZT Systems for $4.9B
GlobeNewswire 08-19 AMD to Significantly Expand Data Center AI Systems Capabilities with Acquisition of Hyperscale Solut...
GlobeNewswire 08-16 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 08-14 Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corp...
GlobeNewswire 08-12 Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corpo...
GlobeNewswire 08-12 Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 08-12 Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire 08-12 AMD Completes Acquisition of Silo AI to Accelerate Development and Deployment of AI Models on AMD Ha...
GlobeNewswire 08-12 Eclipse Life Sciences Initiates Phase 2 Study for Novel Ophthalmology Steroid Implant for Diabetic M...
GlobeNewswire 08-12 Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar po...
GlobeNewswire 08-09 Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire 08-08 4DMT Reports Second Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire 08-08 BOXX Workstations Feature New AMD Ryzen™ 9000 Series Processors
GlobeNewswire 08-08 Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15,...
GlobeNewswire 08-08 Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conferen...
GlobeNewswire 08-08 EyePoint Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conferen...
GlobeNewswire 08-08 YieldMax™ Launches Option Income Strategy ETF on Alibaba (BABA)
GlobeNewswire 08-07 Outlook Therapeutics® to Report Financial Results for Third Quarter Fiscal Year 2024 on August 14, 2...
GlobeNewswire 08-07 Ocular Therapeutix™ Reports Second Quarter 2024 Results
GlobeNewswire 08-07 Ocular Therapeutix™ Announces FDA Feedback That SOL-R Trial is Appropriate as a Registrational Study...